We are live on ! Find out more
GMED icon

Globus Medical

500 hedge funds and large institutions have $9.01B invested in Globus Medical in 2024 Q4 according to their latest regulatory filings, with 104 funds opening new positions, 169 increasing their positions, 153 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more first-time investments, than exits

New positions opened: 104 | Existing positions closed: 43

110% more call options, than puts

Call options by funds: $24.5M | Put options by funds: $11.7M

16% more capital invested

Capital invested by funds: $7.74B → $9.01B (+$1.27B)

11% more funds holding

Funds holding: 449500 (+51)

10% more repeat investments, than reductions

Existing positions increased: 169 | Existing positions reduced: 153

6% more funds holding in top 10

Funds holding in top 10: 1819 (+1)

0.06% more ownership

Funds ownership: 95.72%95.78% (+0.06%)

Holders
500
Holders Change
+51
Holders Change %
+11.36%
% of All Funds
6.59%
Holding in Top 10
19
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+5.56%
% of All Funds
0.25%
New
104
Increased
169
Reduced
153
Closed
43
Calls
$24.5M
Puts
$11.7M
Net Calls
+$12.8M
Net Calls Change
+$2.68M
Name Holding Trade Value Shares
Change
Change in
Stake
CIBC Asset Management
351
CIBC Asset Management
Ontario, Canada
$288K +$13.8K +175 +5%
OTPPB
352
Ontario Teachers' Pension Plan Board
Ontario, Canada
$287K +$274K +3,469 New
BWG
353
Berry Wealth Group
Texas
$282K +$12.9K +164 +5%
MFG
354
MidWestOne Financial Group
Iowa
$282K -$15.1K -192 -5%
PCM
355
Polymer Capital Management
New York
$281K +$268K +3,394 New
PAM
356
Panagora Asset Management
Massachusetts
$279K -$1.97K -25 -0.7%
CI Investments Inc
357
CI Investments Inc
Ontario, Canada
$278K +$4.97K +63 +2%
Cambridge Investment Research Advisors
358
Cambridge Investment Research Advisors
Iowa
$276K +$264K +3,342 New
IWC
359
Integrated Wealth Concepts
Massachusetts
$272K -$1.1K -14 -0.4%
ATC
360
Argent Trust Co
Tennessee
$270K -$1.89K -24 -0.7%
IFU
361
iSAM Funds (UK)
United Kingdom
$256K +$244K +3,097 New
ECM
362
Evergreen Capital Management
Washington
$249K +$15K +190 +7%
CAM
363
Claret Asset Management
Quebec, Canada
$248K +$1.58K +20 +0.7%
AWM
364
Angeles Wealth Management
California
$247K +$236K +2,991 New
VanEck Associates
365
VanEck Associates
New York
$243K -$4.7M -59,571 -95%
Baird Financial Group
366
Baird Financial Group
Wisconsin
$236K -$15.2K -193 -6%
PA
367
Profund Advisors
Maryland
$233K -$3.79K -48 -2%
VI
368
Versor Investments
New York
$231K +$221K +2,798 New
MYAM
369
Meiji Yasuda Asset Management
Japan
$230K +$219K +2,780 New
WANY
370
Wealthspire Advisors (New York)
New York
$225K +$214K +2,716 New
RG
371
Rathbones Group
United Kingdom
$224K +$213K +2,707 New
Osaic Holdings
372
Osaic Holdings
Arizona
$223K -$106K -1,345 -33%
Rafferty Asset Management
373
Rafferty Asset Management
New York
$215K +$205K +2,598 New
AIM
374
Aigen Investment Management
New York
$207K +$197K +2,503 New
SC
375
Schiavi & Co
Delaware
$207K +$197K +2,500 New

GMED Hedge Fund Activity: Q4 2024 in Review

500 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2024, worth a combined $9.01B — up 16% from $7.74B a quarter earlier.

Buyers outnumbered sellers: 104 funds opened new GMED positions and 43 closed out — a net gain of 61 holders — while 169 added to existing stakes and 153 trimmed.

The largest buyer was Millennium Management, adding an estimated $82.5M. The largest seller was Magnetar Financial, cutting an estimated $95.8M.

  • 500 institutional investors held Globus Medical (GMED) as of Q4 2024, up from 449 in Q3 2024.
  • Funds reported $9.01B of Globus Medical stock for Q4 2024, up 16% quarter-over-quarter.
  • 104 funds opened new Globus Medical positions in Q4 2024 and 43 closed out, a net change of +61 holders.
  • The largest Globus Medical buyer in Q4 2024 was Millennium Management, an estimated $82.5M added.
  • The largest Globus Medical seller in Q4 2024 was Magnetar Financial, an estimated $95.8M sold.

Based on aggregated 13F filings for Q4 2024.